Exenatide
Showing 51 - 75 of 425
Alcohol Dependence, in Remission, Addiction, Alcohol Trial in Copenhagen (Exenatide 2 MG Injection, BD PosiFlush (saline))
Completed
- Alcohol Dependence, in Remission
- Addiction, Alcohol
- Exenatide 2 MG Injection
- BD PosiFlush (saline)
-
Copenhagen, Frederiksberg, DenmarkNovavì ambulatorierne
Jun 3, 2021
Diabetes, Type 2, Heart Failure, Diastolic Trial in Houston (Exenatide)
Terminated
- Diabetes Mellitus, Type 2
- Heart Failure, Diastolic
- Exenatide
-
Houston, TexasBaylor College of Medicine
Sep 2, 2020
Polycystic Ovary Syndrome, Obesity Trial in Baton Rouge (Exenatide once weekly (EQW ), Dapagliflozin (DAPA), EQW plus DAPA)
Completed
- Polycystic Ovary Syndrome
- Obesity
- Exenatide once weekly (EQW )
- +4 more
-
Baton Rouge, LouisianaWoman's Hospital
Jan 9, 2021
The Effect of Exenatide on Fasting Bile Acids
Completed
- Type 2 Diabetes Mellitus in Obese
- Exenatide treatment
-
Beijing, ChinaBeijing Chao-yang hospital
Jun 8, 2020
Coronary Disease, Shock, Cardiogenic, Renal Failure Trial in Copenhagen (Byetta (Lilly, Exenatide), Conoxia (AGA, oxygen), 20%
Recruiting
- Coronary Disease
- +5 more
- Byetta (Lilly, Exenatide)
- +2 more
-
Copenhagen, DenmarkRigshospitalet - Copenhagen University Hospital
Apr 15, 2021
Type 2 Diabetes Trial (Exenatide Once-Weekly Suspension)
Withdrawn
- Type 2 Diabetes
- Exenatide Once-Weekly Suspension
- (no location specified)
Jun 2, 2020
Diabetes, Type 1 Trial in Chicago (Islet Cell Transplant, Islet Cell Transplant plus)
Completed
- Diabetes Mellitus, Type 1
- Islet Cell Transplant
- Islet Cell Transplant plus
-
Chicago, IllinoisUniversity of Illinois at Chicago
Mar 11, 2021
Hepatic Steatosis, Polycystic Ovarian Syndrome, Obesity Trial in Aurora (Byetta 5Mcg Pen Injection)
Active, not recruiting
- Hepatic Steatosis
- +2 more
- Byetta 5Mcg Pen Injection
-
Aurora, ColoradoUniversity of Colorado Anshutz Medical Campus/Children's Hospita
Jan 15, 2021
ST Elevation Acute Myocardial Infarction Trial in Spain (Exenatide, Remote Ischemic Conditioning (RIC), Placebo)
Completed
- ST Elevation Acute Myocardial Infarction
- Exenatide
- +2 more
-
Badalona, Barcelona, Spain
- +5 more
Nov 2, 2020
Diabetes, Type 2 Trial in Guadalajara (Exenatide LAR, Dulaglutide)
Unknown status
- Diabetes Mellitus, Type 2
- Exenatide LAR
- Dulaglutide
-
Guadalajara, Jalisco, MexicoInstituto de terapeutica Experimental y Clinica. Centro universi
Mar 24, 2020
Obesity, Diabetes, Type 2 Trial in Oldenburg, Hamburg (Dapagliflozin 10mg, Exenatide 2 mg [Bydureon], Placebo Oral Tablet)
Terminated
- Obesity
- Diabetes Mellitus, Type 2
- Dapagliflozin 10mg
- +5 more
-
Oldenburg, Lower Saxony, Germany
- +3 more
Mar 29, 2020
Type I Diabetes Trial in United States (Exenatide (Bydureon®), Placebo)
Completed
- Type I Diabetes
- Exenatide (Bydureon®)
- Placebo
-
San Francisco, California
- +7 more
Mar 17, 2020
Prader-Willi Syndrome Trial in Sydney (Exenatide)
Completed
- Prader-Willi Syndrome
- Exenatide
-
Sydney, New South Wales, AustraliaGarvan Institute of Medical Research
Jul 3, 2020
Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)
Enrolling by invitation
- Diabetes
- +3 more
- No treatment given
-
Morgantown, West VirginiaUnited BioSource, LLC
Oct 4, 2022
Idiopathic Intracranial Hypertension Trial (Presendin, Placebo)
Not yet recruiting
- Idiopathic Intracranial Hypertension
- Presendin
- Placebo
- (no location specified)
Jul 6, 2022
Polycystic Ovary Syndrome, Overweight and Obesity, Disorder of Glucose Regulation Trial in Shanghai (Exenatide, Metformin)
Completed
- Polycystic Ovary Syndrome
- +2 more
- Exenatide
- Metformin
-
Shanghai, ChinaRenji Hospital Department of Endocrinology and Metabolism
Sep 9, 2019
Brown Adipose Tissue Activity in Response to Semaglutide
Not yet recruiting
- Obesity
- Semaglutide Injectable Product
- (no location specified)
Jan 17, 2023
Obesity, Smoking Cessation, Alcoholism Trial in London (Exenatide, Desacyl ghrelin, Saline)
Unknown status
- Obesity
- +2 more
- Exenatide
- +2 more
-
London, United KingdomCentre for Neuropsychopharmacology, Division of Brain Sciences,
Feb 11, 2020
Long-term Use of Exenatide (Byetta Subcutaneous Injection)
Completed
- Type 2 Diabetes
-
Aichi, Japan
- +45 more
Jul 17, 2020
Diabetes, Type 1 Trial in Gentofte (Exenatide, Placebos)
Completed
- Diabetes Mellitus, Type 1
- Exenatide
- Placebos
-
Gentofte, Capital Region, DenmarkSteno Diabetes Center Copenhagen
Jul 9, 2019